How Pharma Companies Should be Preparing For Brexit

28 May 2019

I realise that most of us, including me, are getting tired of the Brexit issue. However, I am an optimist – I firmly believe that whatever happens there will be big opportunities for all sectors. If you think about, it some of the most successful businesses have been born out of challenges – whether economic, political or other; here are a few examples:

• Microsoft was set up in the middle of one of the worst recessions since WWII.
• The Pony Express was started because the US Postal Service stopped delivering mail beyond certain States in 1858.
• Burberry, that iconic fashion brand, was having serious marketing issues and image problems when ‘chavs’ adopted the brand. It re-invented itself by taking all design work back to the UK and re-launching the brand to what it is today.
• The Body Shop was almost put out of business in its early days because two neighbours who ran funerals parlours nearby objected to the name.

So, whilst I have no doubt the pharmaceutical sector will see huge opportunities whatever happens, the fact is that Brexit is still a big issue for many businesses and those in the pharmaceutical sector are probably facing a more uncertain future than many others; here’s why.

Continue reading (external link)

Back